Won Choi is a Psychiatry physician. ClinicalTrials.gov lists 16 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
645 S Beach Blvd
Anaheim, CA 92804
Telephone
714-821-1993Provider last certified this registry record 15 Feb 2024.
Clinical trials
- Brain Health Project for Korean American Dementia Caregivers
Sponsor: University of California, San Francisco
- Evaluating Student Wellness Using a Blended Approach of the Roadmap mHealth App Plus Wellness Coaching
Sponsor: University of Michigan
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- E.R. Squibb & Sons, L.L.C.Program year20251 payment
- Neurocrine Biosciences, Inc.Program year20231 payment
- Teva Pharmaceuticals USA, Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
85.9%Atypical Antipsychotic41.7%Aripiprazole15%Clozapine14%Olanzapine Odt13%Fanapt10%Quetiapine Fumarate Er10%Quetiapine Fumarate9%Risperidone8%Olanzapine8%Ziprasidone Hcl5%Invega Sustenna4%Asenapine Maleate4%Part D<11 patientsAntihistamine9.7%Benztropine Mesylate69%Hydroxyzine Pamoate31%Part D<11 patients+ 7 more classes in this area
Cardiovascular
10.1%Statin6.6%Atorvastatin Calcium74%Simvastatin27%Part D<11 patientsPeroxisome Proliferator-activated Receptor alpha Agonist1.7%Gemfibrozil100%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
2.4%Proton pump inhibitor2.4%Pantoprazole Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
Philip Scheltens
Inserm
Rafael Tabarés‐Seisdedos
Universitat de València
Nick C. Fox
UK Dementia Research Institute
Perminder S. Sachdev
Department of Health and Aged Care
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”